Click it and Unblock the Notifications
Sensex
81,666.46
+1.17%
|
Nifty
25,088.40
+1.06%
|
22k Gold
₹ 14,039 /gm
|
Silver
₹ 2,99,900/kg
|
Petrol
₹ 103.54
|
Diesel
₹ 90.03
|
Crude Oil
$65.82
|
USD
₹
90.32
|
Sensex
81,666.46
+1.17%
|
Nifty
25,088.40
+1.06%
|
22k Gold
₹ 14,039 /gm
|
Silver
₹ 2,99,900/kg
|
Petrol
₹ 103.54
|
Diesel
₹ 90.03
|
Crude Oil
$65.82
|
USD
₹
90.32
|
Sensex
81,666.46
+1.17%
|
Nifty
25,088.40
+1.06%
|
22k Gold
₹ 14,039 /gm
|
Silver
₹ 2,99,900/kg
|
Petrol
₹ 103.54
|
Diesel
₹ 90.03
|
Crude Oil
$65.82
|
USD
₹
90.32
Tata India Pharma & HealthCare Fund - Direct Plan
Regular
Direct
3 Year Absolute Returns
82.59% ↑
NAV (₹) on 30 Jan 2026
33.46
1 Day NAV Change
1.04%
Risk Level
Very High Risk
Rating
-
Tata India Pharma & HealthCare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by Tata Asset Management Ltd.. Launched on 04 Dec 2015, investors can start with a minimum ... Read more
NAV History
Fund Details
Min. SIP Amount
₹150
Inception Date
04 Dec 2015
Min. Lumpsum Amount
₹ 5,000
Fund Age
10 Yrs
AUM
₹ 1,310.50 Cr.
Benchmark
BSE Healthcare Total Return
Expense Ratio
0.62%
Scheme Type
Open Ended
Exit Load
0.25%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 1,310.50 Cr
Equity
90.83%
Money Market & Cash
9.17%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 59.55% |
| Hospitals & Medical Services | 26.26% |
| Cash | 8.93% |
| Insurance Distributor | 1.68% |
| Fertilisers | 1.12% |
| Chemicals - Speciality | 0.82% |
| Medical Research Services | 0.56% |
| IT Enabled Services | 0.51% |
| Chemicals - Inorganic - Others | 0.29% |
| CBLO/Reverse Repo | 0.24% |
| Medical Equipment & Accessories | 0.04% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11.64% | ₹ 143.32 | Pharmaceuticals |
| CASH / NET CURRENT ASSET | 8.93% | ₹ 109.87 | Others |
| APOLLO HOSPITALS ENTERPRISE LTD | 6.22% | ₹ 76.55 | Hospitals & Medical Services |
| CIPLA LTD | 5.83% | ₹ 71.82 | Pharmaceuticals |
| AUROBINDO PHARMA LTD | 5.73% | ₹ 70.60 | Pharmaceuticals |
| DIVI LABORATORIES LTD | 5.63% | ₹ 69.40 | Pharmaceuticals |
| FORTIS HEALTHCARE LTD | 4.90% | ₹ 60.40 | Hospitals & Medical Services |
| LUPIN LTD | 4.82% | ₹ 59.37 | Pharmaceuticals |
| ASTER DM HEALTHCARE LTD | 4.35% | ₹ 53.52 | Hospitals & Medical Services |
| WOCKHARDT LTD | 3.27% | ₹ 40.28 | Pharmaceuticals |
| DR REDDYS LABORATORIES LTD | 3.16% | ₹ 38.98 | Pharmaceuticals |
| ALKEM LABORATORIES LTD | 3.11% | ₹ 38.37 | Pharmaceuticals |
| HEALTHCARE GLOBAL ENTERPRISES LTD | 2.93% | ₹ 36.13 | Hospitals & Medical Services |
| AJANTA PHARMA LTD | 1.93% | ₹ 23.79 | Pharmaceuticals |
| METROPOLIS HEALTHCARE LTD | 1.86% | ₹ 22.96 | Hospitals & Medical Services |
| TORRENT PHARMACEUTICALS LTD | 1.83% | ₹ 22.52 | Pharmaceuticals |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD | 1.82% | ₹ 22.41 | Hospitals & Medical Services |
| FDC LTD | 1.68% | ₹ 20.68 | Pharmaceuticals |
| MEDI ASSIST HEALTHCARE SERVICES LTD | 1.68% | ₹ 20.74 | Insurance Distributor |
| DR. LAL PATH LABS LTD | 1.66% | ₹ 20.40 | Hospitals & Medical Services |
| IPCA LABORATORIES LTD | 1.65% | ₹ 20.30 | Pharmaceuticals |
| INDOCO REMEDIES LTD | 1.36% | ₹ 16.72 | Pharmaceuticals |
| JUPITER LIFE LINE HOSPITALS LTD | 1.27% | ₹ 15.58 | Hospitals & Medical Services |
| DR. AGARWALS HEALTH CARE LTD | 1.25% | ₹ 15.41 | Hospitals & Medical Services |
| AKUMS DRUGS AND PHARMACEUTICALS LTD | 1.19% | ₹ 14.71 | Pharmaceuticals |
| COROMANDEL INTERNATIONAL LTD | 1.12% | ₹ 13.74 | Fertilisers |
| ZYDUS LIFESCIENCES LTD | 1.04% | ₹ 12.77 | Pharmaceuticals |
| SANOFI INDIA LTD | 0.96% | ₹ 11.87 | Pharmaceuticals |
| AMI ORGANICS LTD | 0.96% | ₹ 11.76 | Pharmaceuticals |
| MEDPLUS HEALTH SERVICES LTD | 0.93% | ₹ 11.48 | Pharmaceuticals |
| MANKIND PHARMA LTD | 0.83% | ₹ 10.23 | Pharmaceuticals |
| SANOFI CONSUMER HEALTHCARE INDIA LTD | 0.82% | ₹ 10.10 | Chemicals - Speciality |
| PROCTER & GAMBLE HEALTH LTD | 0.75% | ₹ 9.20 | Pharmaceuticals |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD | 0.66% | ₹ 8.11 | Pharmaceuticals |
| ORCHID PHARMA LTD | 0.59% | ₹ 7.23 | Pharmaceuticals |
| SYNGENE INTERNATIONAL LTD | 0.56% | ₹ 6.92 | Medical Research Services |
| INVENTURUS KNOWLEDGE SOLUTIONS LTD | 0.51% | ₹ 6.28 | IT Enabled Services |
| DEEPAK NITRITE LTD | 0.29% | ₹ 3.63 | Chemicals - Inorganic - Others |
| REPO | 0.24% | ₹ 3 | Others |
| LAXMI DENTAL LTD | 0.04% | ₹ 0.55 | Medical Equipment & Accessories |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | -1.67% | -0.68% | 11.69% | 22.23% |
| Category returns | 5.58% | 6.26% | 12.22% | 26.95% |
Fund Objective
The investment objective of the scheme is to seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & ... Read more
AMC Details
Name
Tata Asset Management Ltd.
Date of Incorporation
30 Jun 1995
CEO
Mr. Prathit Bhobe
CIO
Mr. Rahul Singh
Type
Pvt.Sector-Indian
Address
1903, B-Wing, Parinee Crescenzo,
G-Block, Bandra Kurla Complex,
Bandra East, Mumbai, Maharashtra, India - 400051
Website
http://www.tatamutualfund.com
Email
service@tataamc.com
Top Funds from Equity - Sectoral/Thematic
Top Funds from Tata Asset Management Ltd.
FAQs
What is the current NAV of Tata India Pharma & HealthCare Fund - Direct Plan Growth?
The current Net Asset Value (NAV) of Tata India Pharma & HealthCare Fund - Direct Plan Growth is ₹33.46 as of 30 Jan 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of Tata India Pharma & HealthCare Fund - Direct Plan Growth?
The Assets Under Management (AUM) of Tata India Pharma & HealthCare Fund - Direct Plan Growth is ₹1,310.50 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of Tata India Pharma & HealthCare Fund - Direct Plan Growth?
Tata India Pharma & HealthCare Fund - Direct Plan Growth has delivered returns of -0.68% (1 Year), 22.23% (3 Year), 16.24% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of Tata India Pharma & HealthCare Fund - Direct Plan Growth?
Tata India Pharma & HealthCare Fund - Direct Plan Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for Tata India Pharma & HealthCare Fund - Direct Plan Growth?
The minimum lumpsum investment required for Tata India Pharma & HealthCare Fund - Direct Plan Growth is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹150, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
Can UAE-Based NRIs Invest In Indian Mutual Funds? Rules, Taxes And DTAA Explained -
What Is A Balanced Advantage Fund (BAF) And How Does It Work? -
Are Retirement Mutual Funds The Right Choice For Long-Term Investment Planning? -
Budget 2026: How the Union Budget Could Impact Your Mutual Fund Investments -
Rs 10,000 SIP Became Rs 29.5 Lakh: This ELSS Fund Outperformed Benchmarks For 10 Years; Here’s How -
Mutual funds boost holdings in nine stocks in November 2025, Ather Energy leads gains -
Mutual Funds Increase Holdings in Nine Stocks in November 2025, Driving Strong FY26 Gains Across Sectors
-
Mutual Funds Take Positions in Nine Stocks with Gains of Up to 115 Percent in FY26
-
Kerala Lottery Bhagyathara, Sthree Sakthi Results: Top 5 Mutual Funds To Invest In 2026 With Rs 1 Crore Prize -
Mutual Fund Calculator: How Much SIP Should I Invest At My Current Age of 27 To Get Rs 1 Cr Corpus In 15 Yrs?
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+